Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Immunomodulatory treatments and cognition in MS.
Brain health: time matters in multiple sclerosis.
Umbilical cord-derived mesenchymal stem cells reversed the suppressive deficiency of T regulatory cells from peripheral blood of patients with multiple sclerosis in a co-culture - a preliminary study.
Step-rate cut-points for physical activity intensity in patients with multiple sclerosis: The effect of disability status.
Early Relapsing Multiple Sclerosis.
Delayed administration of recombinant human erythropoietin reduces apoptosis and inflammation and promotes myelin repair and functional recovery following spinal cord compressive injury in rats.
CDR3 sequence preference of TCRBV8S2+ T cells within the CNS does not reflect single amino acid dependent avidity expansion.
Ultrastructural aspects of mouse nerve-muscle preparation exposed to Bothrops jararacussu and Bothrops bilineatus venoms and their toxins BthTX-I and Bbil-TX: Unknown myotoxic effects.
A placebo randomized controlled study to test the efficacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis - Rationale and design.
Neuroimaging findings of Zika virus infection: a review article.
Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment.
Get glammed up.
Biological Functions of Interferon β-1a Are Enhanced By Deamidation.
Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis.
Distinct origins, gene expression and function of microglia and monocyte-derived macrophages in CNS myelin injury and regeneration.
The Role of Obstructive Sleep Apnea in Cognitive Dysfunction in Multiple Sclerosis.
Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.
T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male.
Long-Term Cost-Effectiveness of Transanal Irrigation in Patients with Neurogenic Bowel Dysfunction.
Increased Immune Reactivity to Central Nervous System Derived Naturally Presented Peptides in Patients with Active Multiple Sclerosis.
Multi-Output Decision Trees for Lesion Segmentation in Multiple Sclerosis.
Potential Benefit of the Charge-Stabilized Nanostructure Saline RNS60 for Myelin Maintenance and Repair.
Predictors of burden and depression among caregivers of relapsing-remitting MS patients in Spain: MS Feeling study.
Posterior reversible encephalopathy syndrome (PRES) as a complication of Guillain-Barre' syndrome (GBS).
Pages
« first
‹ previous
…
752
753
754
755
756
757
758
759
760
…
next ›
last »